Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease
Author(s) -
Jayoung Lim,
InChang Hwang,
HongMi Choi,
Yeonyee E. Yoon,
Goo-Yeong Cho
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0269414
Subject(s) - dapagliflozin , empagliflozin , medicine , diabetes mellitus , renal function , type 2 diabetes , cardiology , kidney disease , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom